The American Enterprise Institute released a report that detailed several proposals of change for the ACA that could possibly be implemented with the next president. Joe Antos, PhD, the Wilson H. Taylor Scholar in Health Care and Retirement Policy at the American Enterprise Institute, said that though these changes would depend on the party in office, implementing them wouldn’t necessarily be easy.
The American Enterprise Institute released a report that detailed several proposals of change for the ACA that could possibly be implemented with the next president. Joe Antos, PhD, the Wilson H. Taylor Scholar in Health Care and Retirement Policy at the American Enterprise Institute, said that though these changes would depend on the party in office, implementing them wouldn’t necessarily be easy.
Transcript (slightly modified)
Do you think change to the ACA is possible at this point? Do you think the proposals put forth in the American Enterprise Institute’s report could possibly be implemented with the next president?
Well I think change is inevitable. The question is, is it going in a reasonable direction or a bad direction? And, is it conscious or unconscious? So I agree that certainly the report that we did with as many proposals as we put forth, something like that is impossible no matter who the president is. It’s too big, it’s simply too big.
However, parts of those proposals, there are aspects of those ideas that I think would be compelling to certainly a republican in office and I think some of those ideas would be accepted by a democrat as well. Not the whole package but some changes. And those changes will probably be more forced by reality than something that you want to do because it seems like a good idea. We’re going to have financial difficulties, we’re going to have continuing problems with access, and these are issues that need to be dealt with.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities
July 30th 2025Key legal, ethical, and compliance considerations for managed care professionals navigating the evolving landscape of psychedelic-assisted therapy include regulatory risks, data privacy challenges, reimbursement limitations, and the need for culturally informed care models.
Read More